【结 构 式】 |
【药物名称】NECA, LS-143766 【化学名称】N5'-Ethyladenosine-5'-uronamide 【CA登记号】84272-21-9 【 分 子 式 】C12H16N6O4 【 分 子 量 】308.29912 |
【开发单位】Abbott (Originator) 【药理作用】Antiplatelet Therapy, Coagulation Disorders Therapy, HEMATOLOGIC DRUGS |
合成路线1
The oxidation of 2',3'-isopropylideneadenosine (I) with potassium permanganate gives 2',3'-isopropylideneadenosine-5'-carboxylic acid (II) which with SOCl2 affords 2',3'-isopropylideneadenosine-5'-carbonyl chloride (III), which is treated first with dry liquid ethylamine and then hydrolyzed with aqueous hydrochloric acid.
【1】 Stein, H.H.; Prasad, R.N.; US 4029884 . |
【2】 Stein, H.H.; Prasad, R.N.; US 3830796 . |
【3】 Stein, H.H.; Prasad, R.N.; US 3914414 . |
【4】 Stein, H.H.; Prasad, R.N.; US 3914415 . |
【5】 Stein, H.H.; Prasad, R.N; US 3931401 . |
【6】 Serradell, M.N.; Blancafort, P.; Castaner, J.; Hopkins, S.J.; NECA. Drugs Fut 1981, 6, 10, 627. |
【7】 Stein, H.H.; Prasad, R.N.; US 3966917 . |
【8】 Tietje, K.; Prasad, R.N.; N1,N6-Etheno-adenosine 5'-(N-ethylcarboxamide). Nucleic Acid Chemistry 1978, 2, 701-707. |
【9】 Harman, R.E.; et al.; Permanganate oxidation of purine nucleosides. Chem Ind 1969, 1141. |
【10】 Savic, M.; Brondyk, H.; Egan, R.S.; Bariana, D.S.; Fung, A.; Tietje, K.; Prasad, R.N.; Stein, H.H.; Modifications of the 5' position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5'-(N-substituted)carboxamides. J Med Chem 1980, 23, 3, 313-319. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 10928 | Ethanamine | 75-04-7 | C2H7N | 详情 | 详情 |
(I) | 17560 | [(3aR,4R,6R,6aS)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methanol | 362-75-4 | C13H17N5O4 | 详情 | 详情 |
(II) | 39020 | (3aR,4S,6R,6aR)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxylic acid | C13H15N5O5 | 详情 | 详情 | |
(III) | 39021 | (3aR,4S,6R,6aR)-6-(6-amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carbonyl chloride | C13H14ClN5O4 | 详情 | 详情 |
Extended Information